X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (297) 297
index medicus (243) 243
humans (225) 225
female (187) 187
breast cancer (140) 140
breast neoplasms - drug therapy (126) 126
middle aged (122) 122
adult (104) 104
chemotherapy (104) 104
aged (103) 103
breast neoplasms - pathology (94) 94
cancer (85) 85
antineoplastic combined chemotherapy protocols - therapeutic use (66) 66
treatment outcome (59) 59
care and treatment (57) 57
disease-free survival (47) 47
metastasis (47) 47
antineoplastic agents - therapeutic use (46) 46
medicine & public health (46) 46
survival (44) 44
trastuzumab (42) 42
aged, 80 and over (41) 41
therapy (38) 38
antineoplastic combined chemotherapy protocols - adverse effects (37) 37
neoplasm metastasis (35) 35
women (35) 35
breast neoplasms - metabolism (34) 34
neoplasm staging (34) 34
antineoplastic agents - adverse effects (32) 32
breast neoplasms - mortality (32) 32
research (32) 32
prognosis (31) 31
abridged index medicus (30) 30
article (29) 29
tumors (28) 28
breast neoplasms - genetics (27) 27
clinical trials (27) 27
patients (27) 27
receptor, erbb-2 - metabolism (27) 27
cancer therapies (26) 26
risk factors (26) 26
analysis (25) 25
health aspects (25) 25
hematology, oncology and palliative medicine (25) 25
bevacizumab (24) 24
paclitaxel (24) 24
trial (24) 24
postmenopausal women (23) 23
quality of life (23) 23
breast neoplasms - therapy (21) 21
capecitabine (21) 21
metastases (21) 21
metastatic breast cancer (21) 21
risk (21) 21
tamoxifen (21) 21
cancer research (20) 20
male (20) 20
drug therapy (19) 19
efficacy (19) 19
endocrine therapy (19) 19
neoadjuvant therapy (19) 19
oncology, experimental (19) 19
chemotherapy, adjuvant (18) 18
endothelial growth-factor (18) 18
expression (18) 18
medicine, general & internal (18) 18
adjuvant chemotherapy (17) 17
antibodies, monoclonal, humanized (17) 17
breast-cancer (17) 17
double-blind (17) 17
everolimus (17) 17
patient outcomes (17) 17
safety (17) 17
usage (17) 17
animals (16) 16
cancer patients (16) 16
clinical trials as topic (16) 16
double-blind method (15) 15
erbb-2 protein (15) 15
prevention (15) 15
receptors, estrogen - metabolism (15) 15
survival analysis (15) 15
antibodies, monoclonal - adverse effects (14) 14
antibodies, monoclonal, humanized - administration & dosage (14) 14
combination (14) 14
drug administration schedule (14) 14
epidermal growth factor (14) 14
her2 (14) 14
kaplan-meier estimate (14) 14
paclitaxel - administration & dosage (14) 14
quality-of-life (14) 14
antibodies, monoclonal - administration & dosage (13) 13
antineoplastic agents (13) 13
breast neoplasms - diagnosis (13) 13
carcinoma (13) 13
gene expression (13) 13
original reports (13) 13
recurrence (13) 13
survival rate (13) 13
young adult (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2012, Volume 109, Issue 8, pp. 2796 - 2801
Retrospective clinical studies have used immune-based biomarkers, alone or in combination, to predict survival outcomes for women with breast cancer (BC);... 
T lymphocytes | Cytometry | Lymphocytes | Breasts | BREAST CANCER SPECIAL FEATURE | Residual neoplasm | Breast cancer | Leukocytes | Macrophages | Tumors | Cancer | Inflammation | Macrophage | INFILTRATING LYMPHOCYTES | MULTIDISCIPLINARY SCIENCES | VEGF EXPRESSION | macrophage | MICROVESSEL DENSITY | MAMMARY-TUMORS | inflammation | MOUSE MODEL | REGULATORY T-CELLS | TUMOR-ASSOCIATED MACROPHAGES | CARCINOMA | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Neoplasm, Residual - pathology | Leukocytes - pathology | Breast Neoplasms - immunology | Humans | Antineoplastic Agents - therapeutic use | Cell Lineage - drug effects | Antigens, CD - metabolism | Leukocytes - immunology | Lymphocyte Activation - immunology | Myeloid Cells - immunology | T-Lymphocytes - drug effects | Biomarkers, Tumor - metabolism | Female | Myeloid Cells - drug effects | Neoadjuvant Therapy | Neoplasm, Residual - immunology | Antineoplastic Agents - pharmacology | T-Lymphocytes - pathology | Cytotoxicity, Immunologic - drug effects | Lymphocytes, Tumor-Infiltrating - drug effects | Breast Neoplasms - drug therapy | Cell Movement - drug effects | Phenotype | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | Lymphocyte Activation - drug effects | Antigens, Differentiation, Myelomonocytic - metabolism | Leukocytes - drug effects | T-Lymphocytes - immunology | Myeloid Cells - pathology | Lymphocytes, Tumor-Infiltrating - immunology | Physiological aspects | Development and progression | Health aspects | Immunohistochemistry | Leucocytes | Biomarkers | T cell receptors | Index Medicus | Biological Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2019, Volume 381, Issue 4, pp. 371 - 372
Journal Article
Journal of Italian Cinema & Media Studies, ISSN 2047-7368, 03/2013, Volume 1, Issue 2, pp. 129 - 141
This article identifies Marco Ferreri's original contribution to cinema as a gesture aimed at exposing the 'end of the world'. This expression should be... 
Marco Ferreri | monuments | end of the world | neo-realism | sense | hope | essential images | hope sense | Neorealism | Ferreri, Marco | film | dramatic arts
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2108 - 2121
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1925 - 1936
Journal Article
European Journal of Cancer, ISSN 0959-8049, 06/2018, Volume 96, pp. 125 - 127
As the patent life ends or is close to ending on a number of novel biologic therapies for cancer therapy, the number of biosimilars in development has... 
BREAST-CANCER | TRASTUZUMAB | ONCOLOGY | Medical Oncology | Neoadjuvant Therapy | Breast Neoplasms | Biosimilar Pharmaceuticals | Humans | Trastuzumab | Organic chemistry | Patents | Biological products | Clinics | Oncology | Pharmacology | Pharmacokinetics | Growth factors | Cancer | Index Medicus
Journal Article
The Breast, ISSN 0960-9776, 11/2017, Volume 36, pp. S29 - S30
Journal Article
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 654 - 662
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 09/2017, Volume 23, Issue 17, pp. 5218 - 5224
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 08/2018, Volume 16, Issue 8, pp. 533 - 537
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 6, pp. 520 - 529
Resistance to hormone therapy through activation of cellular pathways involving mTOR can develop in postmenopausal hormone-receptor–positive breast cancer.... 
TRIAL | WOMEN | MEDICINE, GENERAL & INTERNAL | EFFICACY | TAMOXIFEN | PHASE-III | LETROZOLE | SUPERIOR | AROMATASE INHIBITORS | FIRST-LINE THERAPY | ANASTROZOLE | Recurrence | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aromatase Inhibitors - adverse effects | Breast Neoplasms - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aromatase Inhibitors - therapeutic use | Everolimus | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Receptor, Epidermal Growth Factor - analysis | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Drugs | Care and treatment | Usage | Hormone therapy | Patient outcomes | Drug utilization | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | TOR protein | Anastrozole | Endocrine therapy | Fatigue | Intracellular signalling | Rapamycin | Tamoxifen | Cancer therapies | Survival | Post-menopause | Fulvestrant | Signal transduction | Stomatitis | Hyperglycemia | Chemotherapy | Pneumonitis | Dyspnea | Aromatase | Antitumor activity | Respiration | Index Medicus | Abridged Index Medicus
Journal Article